TTFields treatment following stereotactic radiosurgery prolonged the time to intracranial progression for patients with brain metastases from NSCLC.

Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 ...

Overview of Epigenetics MarketThe global Epigenetics Market is valued at USD 2.56 Billion in 2024 and is projected to reach a value of USD 9.11 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...

Incyte (Nasdaq:INCY) today reported financial results for the third quarter of 2025 and provided a business update.

Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median ...

Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median progression-free ...

Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced initial results from the ongoing Phase 1 ...

About Creative Medical Technology Holdings Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) is a clinical-stage biotechnology company pioneering regenerative medicine solutions across ...

From this core mechanism Fc engineering has evolved over time into the "engine" of therapeutic antibody development. It ...

Q3 2025 Earnings Call October 28, 2025 8:00 AM EDTCompany ParticipantsAlexis SmithWilliam Meury - CEO, President ...

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and ...

Carrots According to a 2008 study at Harvard University, eating 5 carrots during the week may reduce the risk of a stroke by ...